emerg
middl
east
respiratori
syndrom
coronaviru
merscov
global
concern
caus
sever
respiratori
ill
confirm
case
death
therapeut
intervent
evalu
vivo
thu
patient
manag
reli
exclus
support
care
given
high
casefat
rate
highli
effect
rhesu
macaqu
known
diseas
model
merscov
develop
acut
localizedtowidespread
pneumonia
transient
clinic
diseas
recapitul
mildtomoder
human
merscov
case
combin
ribavirin
effect
reduc
merscov
replic
vitro
therefor
strategi
initi
h
postinfect
user
may
view
print
copi
download
text
datamin
content
document
purpos
academ
research
subject
alway
full
condit
use
rhesu
macaqu
model
treat
anim
develop
breath
abnorm
show
notoveri
mild
radiograph
evid
pneumonia
moreov
treat
anim
show
reduc
level
system
serum
local
lung
proinflammatori
marker
addit
reduc
viral
genom
copi
alter
gene
express
less
sever
histopatholog
chang
lung
taken
togeth
data
suggest
treatment
merscov
infect
rhesu
macaqu
ribavirin
reduc
viru
replic
moder
host
respons
improv
clinic
outcom
two
drug
alreadi
use
combin
clinic
ribavirin
consid
manag
merscov
case
merscov
first
lineag
c
betacoronaviru
known
infect
human
similar
sar
infect
result
acut
respiratori
distress
syndrom
multiorgan
dysfunct
rapid
identif
therapeut
merscov
high
prioriti
current
specif
therapi
vaccin
metaanalysi
data
sar
outbreak
conclud
best
benefit
differ
treatment
strategi
inconclus
recent
demonstr
vitro
antivir
effect
merscov
augment
concomit
use
ribavirin
combin
effect
concentr
clinic
achiev
evalu
effect
vivo
combin
ribavirin
treatment
attempt
identifi
therapeut
approach
immedi
implement
clinic
merscov
case
two
group
three
rhesu
macaqu
infect
tissu
cultur
infecti
dose
tcid
merscov
previous
describ
tabl
appear
breath
abnorm
support
evid
decreas
oxygen
satur
untreat
anim
decreas
baselin
fig
significantli
increas
white
blood
cell
count
note
untreat
anim
dpi
return
normal
level
subsequ
day
fig
increas
white
blood
cell
mainli
attribut
signific
increas
neutrophil
fig
contrast
treat
anim
show
evid
increas
respir
piloerect
decreas
oxygen
satur
level
signific
chang
hematolog
fig
e
monitor
sign
pneumonia
anim
underw
daili
xray
radiograph
treat
anim
remain
normal
dpi
show
light
infiltr
singl
lobe
dpi
contrast
untreat
anim
show
evid
increas
amount
interstiti
infiltr
dpi
rang
local
singl
lobe
diffus
sever
pulmonari
interstiti
infiltr
throughout
lung
fig
supplement
tabl
upon
necropsi
gross
patholog
reveal
lung
normal
appear
treat
anim
fig
left
contrast
lung
untreat
anim
firm
edemat
fail
collaps
fig
middl
contain
gross
lesion
mean
affect
area
fig
right
supplement
tabl
multifoc
consolid
dark
red
discolor
consist
interstiti
pneumonia
preval
dorsal
surfac
lung
untreat
anim
patholog
chang
observ
necropsi
quantit
real
time
revers
transcriptas
polymeras
chain
reaction
qrtpcr
use
determin
viral
load
tcid
equival
tissu
fluid
swab
detect
viral
rna
blood
time
point
urin
taken
necropsi
daili
bronchial
alveolar
lavag
sampl
show
similar
viral
load
group
supplement
fig
except
oronasopharynx
treat
anim
respiratori
tract
tissu
collect
necropsi
posit
merscov
qrtpcr
fig
viral
rna
also
absent
tonsil
spleen
kidney
treat
anim
present
two
three
untreat
anim
tissu
analyz
except
left
middl
lobe
lung
specimen
viral
load
lower
specimen
treat
versu
untreat
anim
valu
lung
specimen
combin
mean
viral
load
treat
anim
lower
untreat
anim
unpair
ttest
one
tail
demonstr
statist
signific
reduct
viru
replic
throughout
lung
fig
inset
anim
develop
degre
pulmonari
patholog
multifoc
mildtomark
bronchointerstiti
pneumonia
predominantli
center
termin
bronchiol
fig
howev
untreat
rhesu
macaqu
rm
show
moderatetomark
lesion
abund
alveolar
edema
fibrin
format
hyalin
membran
smalltomoder
number
macrophag
fig
middl
right
lesion
sever
observ
treat
anim
fig
middl
right
supplement
tabl
untreat
anim
show
signific
score
perivascular
infiltr
within
adjac
affect
area
lung
fig
left
p
mannwhitney
increas
number
neutrophil
observ
lung
untreat
anim
compar
fig
serum
level
monitor
assess
deliveri
treat
anim
least
time
level
untreat
anim
dpi
dpi
treat
anim
time
level
untreat
anim
supplement
fig
like
reflect
time
administr
relat
blood
collect
untreat
anim
show
evid
interferon
respons
dpi
mean
pgml
respect
howev
undetect
dpi
treat
anim
show
alter
system
serum
interleukin
il
monocyt
chemotact
protein
mcp
receptor
antagonist
ra
observ
untreat
anim
supplement
elev
local
level
also
observ
homogen
lung
tissu
collect
dpi
untreat
compar
treat
anim
supplement
fig
indic
tissuespecif
host
respons
infect
moder
treatment
effect
treatment
lung
transcriptom
analyz
microarray
rna
extract
right
lower
lobe
rll
singular
valu
decomposit
coupl
multidimension
scale
svdmd
analysi
provid
overal
view
transcriptom
perform
addit
control
lung
tissu
rhesu
macaqu
fig
comparison
group
mean
open
circl
reveal
clear
separ
treat
versu
untreat
lung
rll
sampl
treat
untreat
sampl
also
separ
uninfect
untreat
control
sampl
indic
treatment
induc
uniqu
transcript
chang
use
relax
pvalu
cutoff
p
observ
differenti
express
gene
deg
supplement
tabl
mani
associ
innat
antivir
process
induc
ribavirin
includ
type
ifn
pattern
recognit
receptor
interferoninduc
helicas
c
domain
effector
molecul
associ
signal
transduc
comparison
uninfect
untreat
anim
treat
untreat
infect
anim
reveal
reduct
inflammatori
gene
treat
anim
suggest
milder
diseas
supplement
fig
elucid
mechan
treatment
reduc
inflamm
diseas
merscov
infect
sought
identifi
deg
associ
known
ifnstimul
gene
induct
program
examin
deg
identifi
use
stringent
pvalu
cutoff
p
fig
supplement
tabl
ingenu
pathway
analysi
identifi
mani
gene
downregul
untreat
anim
mani
associ
hedgehog
signal
fig
pathway
involv
respiratori
morphogenesi
vascular
potenti
involv
inflammatori
injuri
treat
anim
observ
upregul
sonic
hedgehog
shh
subsequ
downregul
gene
associ
cell
prolifer
supplement
tabl
shh
prime
protein
hedgehog
pathway
associ
molecul
gli
famili
zinc
finger
shown
block
injuri
respons
pulmonari
vasculatur
induc
multipl
type
inflammatori
stress
stimuli
consist
reduc
inflamm
reduct
cellular
infiltr
lack
perivascul
lung
treat
anim
upregul
shh
suggest
hedgehog
pathway
regul
host
respons
protect
lung
potenti
injuri
inflamm
rhesu
macaqu
treat
ribavirin
hour
postmerscov
infect
show
improv
clinic
paramet
breath
abnorm
littl
evid
pneumonia
xray
addit
treat
anim
show
reduc
system
local
level
proinflammatori
marker
lung
tissu
collect
dpi
show
signific
reduct
viral
genom
copi
absenc
gross
lesion
less
sever
histopatholog
chang
treat
anim
microarray
analysi
lung
support
success
treatment
identifi
hedgehog
signal
pathway
put
contributor
decreas
lung
damag
data
suggest
treatment
merscov
infect
rhesu
macaqu
ribavirin
improv
outcom
infect
ribavirin
treatment
would
expect
provid
greatest
benefit
earli
infect
howev
prolong
diseas
cours
human
suggest
treatment
window
may
consider
longer
reduc
diseas
sever
rhesu
macaqu
model
appear
recapitul
mildtomoder
human
merscov
case
make
difficult
extrapol
outcom
treatment
sever
human
case
thu
current
unknown
whether
initi
treatment
upon
progress
sever
respiratori
ill
would
benefit
situat
face
mani
acut
infecti
diseas
addit
therapeut
evalu
howev
given
sever
poor
outcom
merscov
infect
combin
ribavirin
therapi
consid
earli
intervent
therapi
merscov
infecti
work
merscov
approv
rml
institut
biosafeti
committe
ibc
perform
high
contain
facil
rocki
mountain
laboratori
rml
divis
intramur
research
dir
nation
institut
allergi
infecti
diseas
niaid
nation
institut
health
nih
ibc
approv
standard
oper
procedur
appli
infecti
work
vero
cell
african
green
monkey
kidney
maintain
co
dulbecco
modifi
eagl
media
dmem
supplement
fetal
bovin
serum
fb
uml
penicillin
streptomycin
merscov
isol
hcovemc
subsequ
propag
vero
cell
use
dmem
fb
complet
dmem
anim
experi
approv
institut
anim
care
use
committe
rocki
mountain
laboratori
perform
follow
nih
guid
care
use
laboratori
anim
guidelin
associ
assess
accredit
laboratori
anim
care
intern
aaalac
certifi
staff
aaalac
approv
facil
inocul
six
healthi
rhesu
macaqu
macaca
mulatta
age
year
total
tcid
merscov
combin
intratrach
intranas
oral
ocular
rout
previous
establish
anim
randomli
assign
either
treat
untreat
group
nonblind
manner
treatment
initi
h
postinfect
initi
ribavirin
mp
bioscienc
load
dose
mgkg
deliv
intraven
subsequ
dose
mgkg
deliv
everi
h
intramuscularli
introna
merck
miukg
deliv
subcutan
everi
h
three
anim
receiv
ribavirin
treat
three
anim
receiv
sham
treatment
untreat
rout
compar
volumekg
steril
salin
anim
monitor
three
time
daili
clinic
score
andor
examin
describ
previous
clinic
examin
includ
daili
ventraldors
later
xray
bodi
temperatur
blood
pressur
heart
rate
respir
rate
puls
oximetri
venou
bleed
bronchoalveolar
lavag
collect
swab
nasal
oral
mucosa
boardcertifi
veterinarian
interpret
radiograph
data
dpi
anim
necropsi
conjunctiva
nasal
mucosa
tonsil
oronasopharynx
mandibular
lymph
node
salivari
gland
trachea
right
bronchu
left
bronchu
six
lung
lobe
mediastin
lymph
node
inguin
lymph
node
axillari
lymph
node
mesenter
lymph
node
heart
liver
spleen
kidney
urinari
bladder
collect
virolog
histopatholog
assay
hematolog
analysi
carri
follow
standard
protocol
total
white
blood
cell
count
lymphocyt
platelet
reticulocyt
red
blood
cell
count
hemoglobin
hematocrit
valu
mean
cell
volum
mean
corpuscular
volum
mean
corpuscular
hemoglobin
concentr
determin
edta
blood
hemavet
laserbas
hematolog
analyz
drew
scientif
sampl
lung
lobe
weigh
subsequ
homogen
bioplex
cell
lysi
buffer
biorad
stainless
steel
bead
qiashredd
qiagen
debri
pellet
supernat
remov
serum
tissu
sampl
inactiv
mrad
accord
standard
oper
procedur
total
protein
concentr
tissu
homogen
determin
dc
protein
assay
tissu
place
cassett
fix
neutral
buffer
formalin
day
subsequ
tissu
process
sakura
tissu
tek
h
autom
schedul
use
grade
seri
ethanol
xylen
paraplast
extra
embed
tissu
section
dri
overnight
prior
stain
tissu
section
stain
hematoxylin
eosin
specif
anticov
immunoreact
detect
use
polyclon
rabbit
antibodi
dilut
tissu
also
stain
myeloperoxidasespecif
antibodi
r
system
minneapoli
mn
tissu
process
immunohistochemistri
use
discoveri
xt
autom
processor
ventana
medic
system
dapmap
ventana
medic
system
kit
scan
aperio
scanscop
xt
aperio
technolog
inc
entir
section
analyz
imagescop
posit
pixel
count
algorithm
version
rna
avltreat
blood
rlttreat
tissu
extract
qiaamp
viral
rna
rneasi
kit
respect
qiagen
qrtpcr
use
primer
probe
previous
describ
perform
rotorgen
q
qiagen
dilut
seri
viral
rna
base
tcid
equival
use
standard
microarray
analysi
lung
homogen
store
c
equal
volum
rlt
buffer
qiagen
ethanol
prepar
sampl
thaw
two
addit
volum
rlt
buffer
volum
ad
follow
addit
two
volum
ethanol
rna
extract
use
rneasi
spin
column
per
manufactur
protocol
low
yield
sampl
concentr
use
rna
clean
concentr
zymo
research
probe
label
carri
use
agil
low
input
process
protocol
hybrid
agil
rhesu
macaqu
microarray
agil
technolog
use
manufactur
onecolor
analysi
protocol
comparison
differenti
express
gene
deg
infect
lung
ribavirintr
untreat
anim
raw
array
data
upload
genedata
analyst
genedata
data
normal
use
quantil
normal
method
log
ratio
express
calcul
rel
mean
probe
valu
three
untreat
anim
statist
signific
deg
determin
use
welch
ttest
p
fold
chang
hierarch
cluster
deg
perform
unweight
averag
method
unweight
pair
group
arithmet
mean
upgma
use
spotfir
decisionsit
tibco
analysi
function
enrich
perform
use
ingenu
pathway
analysi
softwar
ingenu
system
measur
gene
express
dynam
array
data
normal
use
neonorm
subject
svdmd
analysi
parallel
data
individu
merg
use
weight
averag
gener
combin
profil
visual
use
svdmd
raw
microarray
data
deposit
ncbi
gene
express
omnibu
databas
access
number
also
avail
public
http
viromicswashingtonedu
except
data
microarray
experi
data
analyz
prism
graphpad
softwar
use
unpair
ttest
twoway
anova
bonferroni
posttest
mann
whitney
test
indic
refer
web
version
pubm
central
supplementari
materi
